
132 - Patricia Bradley CCO: Neurotech Series - MindMaze, Commercialise Neurotechnology
Let us know your thoughts. Send us a Text Message.
Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn.
Episode Title:- 🇨🇭Commercialise Neurotechnology🇨🇭
In this #HTNeurotechSeries episode of Heads Talk, I am joined by Patricia Bradley, Global Chief Commercial Officer of MindMaze and this was a conversation about ‘go to market’ and the unique complexities for a Neurotech startup as opposed to other technology startups in the, for example, financial space.
Definitely one for those of you with a Neurotech startup, ready to scale up enterprise.
A bit about MindMaze: It is a Neurotechnology company that famously became the 1st Swiss unicorn, when in 2016 it raised $100 million Dollars in Series A1 funding.
Topics Covered:
- Neurotech Investors
- Ecosystem (Lack of)
- Commercialised Components to Clinical Trials
- Reimbursement Issues
- The Pitch
- Collaboration with Pharmaceutical Companies
So download⏳grab a cup of Bird & Blend Tea Co - Enchanted Nania Tea ☕️& have a listen🛋
Series Sponsored by - PrivCap Resource Group
Series Partnered with Foresight Institute
Next week's guest announced on LinkedIn every Monday. Follow me to see.
ABOUT THE HOST
HeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeries
MindMaze Testimonials: https://mindmaze.com/testimonials/
Follow, Support, Contact Heads Talk - A Fly On The Boardroom Wall
More episodes from "Heads Talk"
Don't miss an episode of “Heads Talk” and subscribe to it in the GetPodcast app.